1. Home
  2. ENTX vs DUOT Comparison

ENTX vs DUOT Comparison

Compare ENTX & DUOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENTX
  • DUOT
  • Stock Information
  • Founded
  • ENTX 2010
  • DUOT 1990
  • Country
  • ENTX Israel
  • DUOT United States
  • Employees
  • ENTX N/A
  • DUOT N/A
  • Industry
  • ENTX Biotechnology: Biological Products (No Diagnostic Substances)
  • DUOT Computer Software: Prepackaged Software
  • Sector
  • ENTX Health Care
  • DUOT Technology
  • Exchange
  • ENTX Nasdaq
  • DUOT Nasdaq
  • Market Cap
  • ENTX 142.0M
  • DUOT 169.7M
  • IPO Year
  • ENTX 2018
  • DUOT N/A
  • Fundamental
  • Price
  • ENTX $3.14
  • DUOT $9.93
  • Analyst Decision
  • ENTX Strong Buy
  • DUOT Strong Buy
  • Analyst Count
  • ENTX 1
  • DUOT 2
  • Target Price
  • ENTX $10.00
  • DUOT $12.75
  • AVG Volume (30 Days)
  • ENTX 283.9K
  • DUOT 344.1K
  • Earning Date
  • ENTX 11-07-2025
  • DUOT 11-12-2025
  • Dividend Yield
  • ENTX N/A
  • DUOT N/A
  • EPS Growth
  • ENTX N/A
  • DUOT N/A
  • EPS
  • ENTX N/A
  • DUOT N/A
  • Revenue
  • ENTX $166,000.00
  • DUOT $15,387,935.00
  • Revenue This Year
  • ENTX N/A
  • DUOT $292.26
  • Revenue Next Year
  • ENTX N/A
  • DUOT $43.21
  • P/E Ratio
  • ENTX N/A
  • DUOT N/A
  • Revenue Growth
  • ENTX 191.23
  • DUOT 172.93
  • 52 Week Low
  • ENTX $1.50
  • DUOT $3.71
  • 52 Week High
  • ENTX $3.22
  • DUOT $11.23
  • Technical
  • Relative Strength Index (RSI)
  • ENTX 71.14
  • DUOT 57.93
  • Support Level
  • ENTX $2.45
  • DUOT $9.77
  • Resistance Level
  • ENTX $3.22
  • DUOT $11.23
  • Average True Range (ATR)
  • ENTX 0.23
  • DUOT 0.71
  • MACD
  • ENTX 0.05
  • DUOT 0.02
  • Stochastic Oscillator
  • ENTX 89.09
  • DUOT 55.27

About ENTX Entera Bio Ltd.

Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to significantly shift a treatment paradigm. Its product candidates are; EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism are first-in-class mini tablet formulations of synthetic human PTH (1-34) (teriparatide), designed to have differing pharmacokinetic, or PK, profiles.

About DUOT Duos Technologies Group Inc.

Duos Technologies Group Inc operating under its brand name duostech, designs, develops, deploys and operates intelligent technology solutions supporting rail, logistics and intermodal businesses that streamline operations, improve safety and reduce costs. The company's main offering, the Railcar Inspection Portal (RIP), provides both freight and transit railroad customers and select government agencies the ability to conduct fully automated railcar inspections of trains that are moving at full speed. It has also developed the Automated Logistics Information System (ALIS) which automates gatehouse operations where transport trucks enter and exit large logistics and intermodal facilities. Its segments are Rail, Commercial, Governments, Banking and AI.

Share on Social Networks: